This is a routine draw under an existing facility with no new terms. Monitor the company's cash burn rate and any future draws that may signal liquidity pressure, especially given the lender's affiliation with the largest stockholder.
Price Chart
Executive Summary
TuHURA Biosciences drew an additional $650,000 under its existing $50M revolving credit facility with Parkview Holdings One LLC for general corporate purposes. The draw is a routine incremental borrowing under a previously disclosed facility and does not represent new debt terms or a change in financial condition. Given the small size relative to the $50M facility and the company's $149M market cap, this is a low-impact administrative event.
Key Facts
- TuHURA borrowed an additional $650,000 under its existing $50M revolving credit facility on August 7, 2026.
- The facility matures on April 21, 2031, and was originally entered into on April 21, 2026.
- Proceeds are for general corporate purposes.
- The lender, Parkview Holdings One LLC, is an affiliate of the company's largest stockholder, creating a potential conflict of interest.
Financial Impact
Incremental debt of $650,000 drawn under a $50M revolving credit facility; total drawn amount not disclosed.
Risk Factors
- Potential conflict of interest with lender affiliate of largest stockholder
- Risk that available funds under the facility may be insufficient to fund operations and development programs
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-349540 |
| Document: 0001193125-26-349540-index-headers.html | 0001193125-26-349540 |
| Document: 0001193125-26-349540-index.html | 0001193125-26-349540 |
| Document: 0001193125-26-349540.txt | 0001193125-26-349540 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | 8-K | $1.78 | awaiting T+60 | — | $2.03 (+14.04%) |
Sep 24, 2026 4w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 17, 2026 5w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 16, 2026 5w ago | 8-K | $2.09 | awaiting T+60 | — | $2.03 (−2.87%) |
Sep 4, 2026 7w ago | 8-K | $2.12 | awaiting T+60 | — | $2.03 (−4.25%) |
Aug 19, 2026 9w ago | 8-K | $2.22 | awaiting T+60 | — | $2.03 (−8.56%) |
Aug 14, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 14, 2026 10w ago | Press Release | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 13, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Jul 29, 2026 12w ago | 8-K | $2.17 $2.18 | ▲ +0.46% | ▼ −2.00% | $2.03 (−6.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers